glp-1 sglt2 combination Illustration of potential synergistic effects of inhibitor with GLP-1 Receptor Agonists and SGLT2

GLP-1 use was tied to lower odds for hospitalization and ED visits

Diabetes Res Clin Pract 2014;104:9296

For instance, while many companies require a BMI of 30 or higher, or 27 or higher, with a weight-related medical condition, some are now requiring a BMI of 35 or above to qualify, said Eileen Pincay, national pharmacy practice leader at Segal, a benefits and human resources consulting firm

GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications created to treat type 2 diabetes by helping the pancreas release insulin when blood sugar levels are high

By focusing on people, not just numbers, we help our clients find success that lasts a lifetime

Medication costs are separate and are paid directly by the brand-name partner after approval